Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1

The future is now: Model-based clinical trial design for Alzheimer's disease

(2015) K Romero et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prioritized research recommendations from the National Institute of Neurological Disorders and StrokeParkinson'sDisease 2014 conference

(2014) Beth-Anne Sieber et al.   ANNALS OF NEUROLOGY

Approaches and Costs for Sharing Clinical Research Data

(2014) Erin E. Wilhelm et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression

(2014) Robert Küffner et al.   NATURE BIOTECHNOLOGY

The driving role of consortia on the critical path to innovative therapies

(2014) Janet Woodcock et al.   NATURE REVIEWS DRUG DISCOVERY

Paving the critical path of drug development: the CDER perspective

(2014) Janet Woodcock   NATURE REVIEWS DRUG DISCOVERY

The PRO-ACT database: Design, initial analyses, and predictive features

(2014) N. Atassi et al.   NEUROLOGY

Functional connectivity in the basal ganglia network differentiates PD patients from controls

(2014) K. Szewczyk-Krolikowski et al.   NEUROLOGY

The Honolulu-Asia Aging Study: Epidemiologic and Neuropathologic Research on Cognitive Impairment

(2013) Rebecca P. Gelber et al.   Current Alzheimer Research

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease

(2013) M. Rolinski et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results

(2013) A. J. Noyce et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

(2013) Caroline H Williams-Gray et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multiple Sclerosis Outcome Assessments Consortium: Genesis and initial project plan

(2013) Richard A Rudick et al.   Multiple Sclerosis Journal

Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study

(2013) A. J. Yarnall et al.   NEUROLOGY

The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort

(2013) Konrad Szewczyk-Krolikowski et al.   PARKINSONISM & RELATED DISORDERS

New Frontiers for Collaborative Research

(2013) M. Goldman   Science Translational Medicine

The Innovative Medicines Initiative: A European Response to the Innovation Challenge

(2012) M Goldman   CLINICAL PHARMACOLOGY & THERAPEUTICS

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease

(2012) A. Berardelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

Non-motor symptoms of Parkinson’s disease: the patient’s perspective

(2012) Kieran C. Breen et al.   JOURNAL OF NEURAL TRANSMISSION

Combining patient-level and summary-level data for Alzheimer’s disease modeling and simulation: a beta regression meta-analysis

(2012) James A. Rogers et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease

(2009) Venkatesh Atul Bhattaram et al.   AAPS Journal

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS